CEFP Social Security Working Group Raises Questions on Price Maintenance Premium, Biosimilar Policy

April 12, 2017
The Council on Economic and Fiscal Policy’s (CEFP) social security working group discussed issues surrounding drug pricing and distributions on April 11, with members casting questions over the current scheme of the so-called price-maintenance premium for on-patent drugs and stalling...read more